BOBBY GEORGE: Open Payments
NPI 1295267144 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 51 payments from 15 companies in 2025. Trend: 2023 $346 · 2024 $1,216 · 2025 $1,627
Food & beverage: $1,627
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $407 |
| Boston Scientific Corporation | 8 | $229 |
| UCB, Inc. | 7 | $186 |
| Stryker Corporation | 1 | $174 |
| Novartis Pharmaceuticals Corporation | 12 | $170 |
| Globus Medical, Inc. | 3 | $130 |
| ABBVIE INC. | 4 | $99 |
| Genentech USA, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
Products named: MAZOR X SYSTEM, ENROUTE Transcarotid Neuroprotection System, N/A, KESIMPTA, Rystiggo, BOTOX, Fintepla, Ocrevus Zunovo.
Industry payments across TX — which companies pay providers there.
